NSEShareholders meeting1 Jul 2026 · 1 Jul 2026, 06:22 pm

Shareholders meeting

RPG Life Sciences Limited · RPGLIFE

✦ AI SummaryResults

RPG Life Sciences Limited has announced its 19th Annual General Meeting (AGM) to be held on July 23, 2026, through video conferencing. The company has submitted its Annual Report for the financial year 2025-26, including the Business Responsibility and Sustainability Report, to the members of the company.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Notice of 19th Annual General Meeting of the Company

Attachments (1)

📄

RPGLIFE_01072026181947_Initmation_letter.pdf

pdf

Download →
View document text
July 01, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Plot Corporate Relationship Department No. C-1, G- Block, 25, P.J. Towers, Bandra - Kurla Complex, Dalal Street, Mumbai Bandra (East), 400 001. Mumbai – 400 051. Symbol: RPGLIFE Scrip Code: 532983 Dear Sirs /Madam, Sub: Notice of Nineteenth Annual General Meeting, Annual Report FY 2025-26 and the Business Responsibility and Sustainability Report. This is further to our Letter dated June 22, 2026, conveying that the Nineteenth Annual General Meeting ("AGM") of the Members of the Company will be held on Thursday, July 23, 2026, at 3.00 p.m. (IST) through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2025-26 including the Business Responsibility and Sustainability Report, along with the Notice of AGM, which are being sent through electronic mode to the Members of the Company, whose e-mail IDs are registered with Depositories/ Company/ Registrar and Share Transfer Agent. The Annual Report and Notice of AGM are also available on the website of the Company at www.rpglifesciences.com under "Annual Report" tab under "Investors" Section. The Notice of AGM of the Company inter alia indicates the process and manner of remote e-voting/ e-voting at the AGM and instructions for participation at the AGM through VC/OAVM. Request you to kindly take the same on record. Thanking you, Yours faithfully, For RPG Life Sciences Limited Rajesh Shirambekar Head – Legal & Company Secretary Encl: as above Accelerate Intelligence, Embrace Excellence. 2025–2026 ANNUAL REPORT About RPG Accelerate Contents BUILT ON TRUST, DRIVEN BY INNOVATION CORPORATE OVERVIEW Intelligence, A US$ 5.2 billion diversified global conglomerate, RPG Group was founded in 1979 by the legendary 02 About RPG Life Sciences industrialist Dr. R.P. Goenka and has a lineage dating to the early 19th century. Today, its businesses span 04 Business Overview key sectors of infrastructure, tyres, IT & technology, pharmaceuticals, energy products and plantations 12 Chairman’s Message among others, with a footprint in over 135 countries. RPG Group’s prominent companies include CEAT, Embrace 14 MD’s Message KEC International, Zensar Technologies, RPG Life Sciences, Raychem RPG, Harrisons Malayalam and 16 Key Milestones Spencer International Hotels. The Group is home to over 35,000 RPGians from 40 nationalities and is 17 Growth with Purpose, Profit widely recognised for its high standards of corporate governance and a culture of respect for people with Discipline and the environment. Excellence. 18 Financial Highlights 20 International Formulations 21 APIs - Business Continuity 22 Quality-Centric Operations with Scalable Capabilities The pharmaceutical industry is entering a new era that 25 Leveraging Digitalisation to Enhance is defined by the convergence of science, data, and Business Performance intelligent systems. As disease profiles evolve and patient 26 Inspiring Performance through a expectations rise, the ability to act faster, decide sharper, Culture of Happiness and execute better is no longer a competitive advantage; it is a baseline expectation. Across the globe, organisations 27 External Awards & Recognition “Hello Happiness” is our passion and our guiding principle. It reflects our core values and who we are: that learn quickly and operate intelligently are the ones 28 Ensuring Holistic shaping the future of healthcare. Development of Communities unlocking potential, enriching lives, exceeding expectations and building a joyful environment. 32 Focused Areas that Drive Impact “Hello Happiness” underlines RPG Group’s unwavering commitment to creating a positive ripple At RPG Life Sciences, our theme for the year, Accelerate 34 Board of Directors Intelligence, Embrace Excellence, reflects this conviction. effect. Our people, products, services and initiatives all contribute to a better world for our customers 35 Corporate Information We are embedding intelligence across every layer of our and investors through sustainable growth. We foster a work environment that prioritises employee enterprise: in how we research and develop molecules, development, satisfaction and well-being. how we manufacture at scale, how we engage the medical community, and how we serve our patients. “Hello Happiness” is our firm belief in the transformative effect of workplace happiness, which can From AI-led decision support to digitally-enabled field STATUTORY REPORTS enhance performance, creativity, collaboration and resilience. It is action-oriented to finding and operations, from data-driven manufacturing to insight- achieving our purpose in life, both organisational and personal. It is a proud proclamation that we are rich commercial strategy, we are building an organisation 36 Board’s Report an organisation where happy people keep the interests of all our stakeholders ahead of themselves, that thinks faster and acts with greater precision. 54 Management Discussion and becoming a force for positive change. Analysis Report Excellence, for us, is the natural outcome of this pursuit. It 57 Corporate Governance Report is the discipline of doing the right things, consistently and 72 Business Responsibility & well. As we accelerate intelligence across the business, Sustainability Report we remain anchored in our enduring purpose of Building a Healthier Tomorrow, Together. FINANCIAL STATEMENTS 96 Standalone Financial Statements 171 Consolidated Financial Statements 246 AOC-1 Scan this code with a QR reader app on your smartphones or tablets and know more about us. NOTICE You can also find this report online 247 Notice of AGM www.rpglifesciences.com RPG Life Sciences Limited About RPG Life Sciences 50+ years Leader in the of Rich Legacy Immunosuppressant therapy 63+ Integrated countries Operations with export relationships with strong R&D manufacturing capabilities in both APIs and Formulations 6 textbook Robust brands relationships RPG Life Sciences is an integrated pharmaceutical company operating in trusted by patients and doctors with leading global generic players the Domestic and International markets in the Branded Formulations, Global Manufacturing Presence Generics, and Synthetic APIs. Facilites We are a research-based pharmaceutical company producing a in both acute, wide range of quality and affordable medicines. sub-chronic & chronic therapies API and Formulations VALUES Purpose 1,445+ delivering patient happiness Employees across locations Respect Openness Integrity Passion Courage through Innovation and Trust CORPORATE OVERVIEW STATUTORY REPORTS FINANCIAL STATEMENTS Business Overview Key Brands TEXT BOOK BRAND PORTFOLIO REVENUE MIX BY CATEGORIES Domestic Formulations International Formulations IMMUNOSUPPRESSANT BRAND PORTFOLIO DOMESTIC FORMULATIONS The Domestic Formulations business operates in the Mass, Mass Specialty and Specialty segments and accounts for 69% of the 0.25 revenues. The Company focuses on developing, H Head Office 0 1 2.5 manufacturing, and marketing branded finished Mumbai, Maharashtra dosage formulations in India and Nepal. Warehouses The Company has a strong presence in acute, Ankleshwar, Gujarat and Ghaziabad, Uttar Pradesh sub-chronic & chronic therapy areas and is focusing on product portfolio rejuvenation M Manufacturing Units through new launches. Ankleshwar, Gujarat and Navi Mumbai, Maharashtra Map not to scale. For illustrative purposes only. Disclaimer: All the products displayed/mentioned in this Annual Report are for illustration purpose only. Consult your Physician for professional medical advice. RPG Life Sciences Limited Annual Report 2025-26 CORPORATE OVERVIEW STATUTORY REPORTS FINANCIAL STATEMENTS NEW BRAND PORTFOLIO – SPECIALTY CARE NEW BRAND PORTFOLIO - PRIMARY CARE D [Showing first 8,000 characters — download PDF for full document]